Open AccessEffect of xymedone on the vasculothrombocytic hemostasis in patients with ischemic heart disease
Author(s) -
I. Z. Solovieva,
О. Б. Ибрагимов,
E. M. Stolpner,
V. F. Epiphany,
A. I. Tsibulkin,
N. A. Alkhanova,
И. Х. Валеева,
M. B. Kondratieva,
Izida Minullina,
N. V. Motina
Publication year - 1996
Publication title -
kazanskij medicinskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2587-9359
pISSN - 0368-4814
DOI - 10.17816/kazmj90945
Subject(s) - hemostasis , medicine , platelet , plasminogen activator , endothelium , tissue plasminogen activator , cardiology , vascular wall , platelet aggregation , regeneration (biology) , drug , pharmacology , biology , microbiology and biotechnology
The effect of medicinal drugs regenerating the vascular endothelium, in particular, xymedone on the vas- culothrombocytic hemostasis is studied. It is stated that the drug in daily dose equal to 1,5g prescribed during one month does not influence essentially the clinical dynamics, functional characteristics, lipid metabolism, serum atherogenicity, and aggregational ability of thrombocytes in patients with stress stenocardia, however, promotes the regeneration of plasminogen tissue activator level and fibrinolytic potential of the vascular wall.